Top Markets
Coin of the day
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

BVXV
Clasificación en acciones #38547
BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company... BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeutic products designed for the prevention and treatment of a range of infectious and other medical conditions. The company has established strategic licensing and collaboration agreements with prominent scientific institutions, notably the Max Planck Society and the University Medical Center Göttingen. These partnerships are geared towards the advancement and commercialization of nanosized antibodies (NanoAbs), including a specific candidate for COVID-19, and extending this technology to address various other disease indications. Founded in 2003, BiondVax maintains its corporate headquarters in Jerusalem, Israel.
Precio por acción
$0.8
Última sincronización: 2023-10-03
Capitalización bursátil
$922.40K
Cambio (1 día)
-5.88%
Cambio (1 año)
0.00%
País
IL
Comercio BiondVax Pharmaceuticals Ltd. (BVXV)

Categoría

EPS de BiondVax Pharmaceuticals Ltd. (BVXV)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de BiondVax Pharmaceuticals Ltd., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de BiondVax Pharmaceuticals Ltd. desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE